Коррекция негативного побочного действия мебендазола на клеточный иммунитет (2016)

Other · Мамыкова О. И. · 2016

Мамыкова О. И., 2016: Russian-language 2016 article whose title reports correcting a negative side effect of mebendazole on cellular immunity, studied alongside the immunomodulator roncoleukin (rIL-2).

Коррекция негативного побочного действия мебендазола на клеточный иммунитет

Мамыкова О. И., 2016: Russian-language 2016 article whose title reports correcting a negative side effect of mebendazole on cellular immunity, studied alongside the immunomodulator roncoleukin (rIL-2). NON-ENGLISH DOCUMENT. Original title: 'Коррекция негативного побочного действия мебендазола на клеточный иммунитет'. English translation of the title: 'Correction of the negative side effect of mebendazole on cellular immunity'. English translation of the quoted line: same as the title, because the quote is the printed title line of this article (a record field, not a sentence drawn from the body). Author: Мамыкова О. И. (Mamykova O. I.). Journal: Теория и практика борьбы с паразитарными болезнями (Theory and Practice of Combating Parasitic Diseases), 2016. Study type: animal/laboratory immunology, by title and abstract; N, dose, route and schedule not available because only the title and abstract were read. Country: Russia. Funder and declared conflicts: not stated on the page. Comparator: roncoleukin (recombinant IL-2) alone and in combination. This is the one document in the sweep that describes mebendazole as suppressing cellular immunity rather than activating it; it is a parasitology paper, not a cancer paper, and the full text was not opened.